Evidence map›Paper›PMID 35963449›Full record

ArticleNeuropharmacology2022

Characterization and mu opioid receptor sensitivity of neuropeptide Y interneurons in the mouse nucleus accumbens.

Cassandra L Retzlaff, Patrick E Rothwell

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Cassandra L RetzlaffDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, 55455, USA.
Patrick E RothwellDepartment of Neuroscience, University of Minnesota, Minneapolis, MN, 55455, USA. Electronic address: rothwell@umn.edu.
University of Minnesota · US

Funding

Viral Innovation CoreP30DA048742 · NIDA · UNIVERSITY OF MINNESOTA · PI TIMOTHY J EBNER · 2020 to 2026
$19.0M
DAT-Regulation of Nucleus Accumbens Microcircuitry by Oxycodone Exposure and WithdrawalR01DA048946 · NIDA · UNIVERSITY OF MINNESOTA · PI ROTHWELL, PATRICK · 2019 to 2023
$1.9M
Nucleus accumbens synaptic mechanisms of opiate reward and aversionR00DA037279 · NIDA · UNIVERSITY OF MINNESOTA · PI ROTHWELL, PATRICK · 2016 to 2018
$747k
Nucleus accumbens synaptic mechanisms of opiate reward and aversionK99DA037279 · NIDA · STANFORD UNIVERSITY · PI ROTHWELL, PATRICK · 2015 to 2015
$175k
NIDA NIH HHS K99 DA037279NIDA NIH HHS P30 DA048742NIDA NIH HHS R00 DA037279NIDA NIH HHS R01 DA048946
6 · The paper itself

Abstract

Inhibitory interneurons represent less than 5% of neurons within the nucleus accumbens, but are critical for proper microcircuit function within this brain region. In the dorsal striatum, neuropeptide Y is expressed by two interneuron subtypes (low-threshold spiking interneurons and neurogliaform interneurons) that exhibit mu opioid receptor sensitivity in other brain regions. However, few studies have assessed the molecular and physiological properties of neuropeptide Y interneurons within the nucleus accumbens. We used a transgenic reporter mouse to identify and characterize neuropeptide Y interneurons in acute nucleus accumbens brain slices. Nearly all cells exhibited electrophysiological properties of low-threshold spiking interneurons, with almost no neurogliaform interneurons observed among neuropeptide Y interneurons. We corroborated this pattern using fluorescent in situ hybridization, and also identified a high level of mu opioid receptor expression by low-threshold spiking interneurons, which led us to examine the functional consequences of mu opioid receptor activation in these cells using electrophysiology. Mu opioid receptor activation caused a reduction in the rate of spontaneous action potentials in low-threshold spiking interneurons, as well as a decrease in optogenetically-evoked GABA release onto medium spiny neurons. The latter effect was more robust in female versus male mice, and when the postsynaptic medium spiny neuron expressed the Drd1 dopamine receptor. This work is the first to examine the physiological properties of neuropeptide Y interneurons in the nucleus accumbens, and show they may be an important target for mu opioid receptor modulation by endogenous and exogenous opioids.

Indexed as

Neuropeptide YNucleus AccumbensAnimalsFemaleIn Situ Hybridization, FluorescenceInterneuronsMaleMiceMice, TransgenicReceptors, Opioid, muNeuropeptide YReceptors, Opioid, muElectrophysiologyFluorescent in situ hybridizationInterneuronMu opioid receptorNucleus accumbensOptogenetics

Identifiers

PMID35963449
PMCPMC10116437
OpenAlexW4291397452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.